Evaluation of pancreatic tissue penetration of Meronem [meropenem] in the prophylaxis of septic complications in severe pancreatitis

Trial Profile

Evaluation of pancreatic tissue penetration of Meronem [meropenem] in the prophylaxis of septic complications in severe pancreatitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Meropenem (Primary)
  • Indications Bacterial infections; Pancreatitis; Sepsis
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 04 Sep 2017 Last checked against ClinicalTrials.gov record
    • 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top